SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,598,000 | +29.3% | 16,334 | -22.1% | 0.58% | +19.1% |
| Q4 2018 | $2,010,000 | -23.1% | 20,979 | +13.4% | 0.49% | +0.2% |
| Q3 2018 | $2,614,000 | +5.5% | 18,507 | +17.0% | 0.49% | +1.5% |
| Q2 2018 | $2,477,000 | -52.4% | 15,823 | -51.0% | 0.48% | -50.5% |
| Q1 2018 | $5,199,000 | +176.8% | 32,278 | +7.1% | 0.97% | +84.9% |
| Q3 2017 | $1,878,000 | -32.5% | 30,144 | -13.7% | 0.52% | -36.4% |
| Q2 2017 | $2,782,000 | +1.3% | 34,936 | -9.6% | 0.82% | +19.7% |
| Q1 2017 | $2,747,000 | – | 38,651 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |